» Articles » PMID: 30635291

Which Definition of a Central Tumour is More Predictive of Occult Mediastinal Metastasis in Nonsmall Cell Lung Cancer Patients with Radiological N0 Disease?

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2019 Jan 13
PMID 30635291
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Guidelines recommend invasive mediastinal staging for centrally located tumours, even in radiological N0 nonsmall cell lung cancer (NSCLC). However, there is no uniform definition of a central tumour that is more predictive of occult mediastinal metastasis.

Methods: A total of 1337 consecutive patients with radiological N0 disease underwent invasive mediastinal staging. Tumours were categorised into central and peripheral by seven different definitions.

Results: About 7% (93 out of 1337) of patients had occult N2 disease, and they had significantly larger tumour size and more solid tumours on computed tomography. After adjustment for patient- and tumour-related characteristics, only the central tumour definition of the inner one-third of the hemithorax adopted by drawing concentric lines arising from the midline significantly predicted occult N2 disease (adjusted OR 2.13, 95% CI 1.17-3.87; p=0.013). This association was maintained after excluding patients with pure ground-glass nodules (adjusted OR 2.54, 95% CI 1.37-4.71; p=0.003) or only including those with solid tumours (adjusted OR 2.30, 95% CI 1.08-4.88; p=0.030).

Conclusions: We suggest that a central tumour should be defined using the inner one-third of the hemithorax adopted by drawing concentric lines from the midline. This is particularly useful for predicting occult N2 disease in patients with NSCLC.

Citing Articles

Clinical and Bronchoscopy Assessment in Diagnosing the Histopathology Type of Primary Central Lung Tumors.

Elhidsi M, Zaini J, Rachmadi L, Asmarinah A, Kekalih A, Soeroso N Open Respir Med J. 2024; 18:e18743064318977.

PMID: 39130646 PMC: 11311725. DOI: 10.2174/0118743064318977240531100045.


[Impact of the Size and Depth of Pulmonary Nodules on the Surgical Approach 
for Lung Resection in the Treatment of Early-stage Lung Cancer ≤2 cm].

Tang Z, Ge W, Zhou D, He Z, Xu J, Pan X Zhongguo Fei Ai Za Zhi. 2024; 27(3):170-178.

PMID: 38590191 PMC: 11002195. DOI: 10.3779/j.issn.1009-3419.2024.101.08.


Machine learning model for circulating tumor DNA detection in chronic obstructive pulmonary disease patients with lung cancer.

Shin S, Cha S, Lee H, Shin S, Kim Y, Park D Transl Lung Cancer Res. 2024; 13(1):112-125.

PMID: 38404987 PMC: 10891398. DOI: 10.21037/tlcr-23-633.


Role of invasive mediastinal nodal staging in survival outcomes of patients with non-small cell lung cancer and without radiologic lymph node metastasis: a retrospective cohort study.

Kim H, Jeon Y, Um S, Shin S, Jeong B, Lee K EClinicalMedicine. 2024; 69:102478.

PMID: 38361994 PMC: 10867420. DOI: 10.1016/j.eclinm.2024.102478.


Clinical Effect of Endosonography on Overall Survival in Patients with Radiological N1 Non-Small Cell Lung Cancer.

Kim B, Jeong B, Park G, Kim H, Shim Y, Shin S Cancer Res Treat. 2023; 56(2):502-512.

PMID: 38062710 PMC: 11016646. DOI: 10.4143/crt.2023.840.


References
1.
Okiemy G, Foucault C, Avisse C, Hidden G, Riquet M . Lymphatic drainage of the diaphragmatic pleura to the peritracheobronchial lymph nodes. Surg Radiol Anat. 2003; 25(1):32-5. DOI: 10.1007/s00276-002-0081-y. View

2.
Riquet M, Assouad J, Bagan P, Foucault C, Le Pimpec Barthes F, Dujon A . Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann Thorac Surg. 2004; 79(1):225-33. DOI: 10.1016/j.athoracsur.2004.06.081. View

3.
Ketchedjian A, Daly B, Fernando H, Florin L, Hunter C, Morelli D . Location as an important predictor of lymph node involvement for pulmonary adenocarcinoma. J Thorac Cardiovasc Surg. 2006; 132(3):544-8. DOI: 10.1016/j.jtcvs.2006.05.023. View

4.
Lee P, Port J, Korst R, Liss Y, Meherally D, Altorki N . Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg. 2007; 84(1):177-81. DOI: 10.1016/j.athoracsur.2007.03.081. View

5.
Hellwig D, Graeter T, Ukena D, Groeschel A, Sybrecht G, Schaefers H . 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?. J Nucl Med. 2007; 48(11):1761-6. DOI: 10.2967/jnumed.107.044362. View